Vitamin B12 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Vitamin B12
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Vitamin B12

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 11 USDMF, 7 CEP/COS, 4 JDMF, 12 NDC API, 22 Listed Suppliers, $ API Reference Price

37 API Suppliers
11 USDMF
7 CEP/COS
4 JDMF
12 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

273 FDF Dossiers, 75 FDA Orange Book, 43 Europe, 15 Canada, 41 South Africa, 99 Listed Dossiers

273 FDF Dossiers
75 FDA Orange Book
43 Europe
15 Canada
41 South Africa
99 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 1MG/ML, INJECTABLE;INJECTION - 1MG/ML, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
INJECTABLE;INJECTION - 1MG/ML
INJECTABLE;INJECTION - 1MG/ML
INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 Evonik, 13 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 20 DKSH, 2 Jai Radhe Sales, 2 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 2 Kewpie Corporation, 14 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 19 Actylis, 3 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 36 BASF, 1 Bioplus Life Sciences, 2 Clariant, 13 Corel Pharma Chem, 3 DFE Pharma, 3 Doshion Polyscience, 4 Finar, 13 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 21 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 12 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 39 Roquette, 16 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 50 Thickeners and Stabilizers, 47 Solubilizers, 46 Direct Compression, 45 Taste Masking, 42 Parenteral, 38 Controlled & Modified Release, 36 Topical, 35 Disintegrants & Superdisintegrants, 30 Film Formers & Plasticizers, 29 Granulation, 25 Lubricants & Glidants, 23 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 17 Emulsifying Agents, 14 Rheology Modifiers, 10 API Stability Enhancers, 9 Empty Capsules, 7 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

96 Fillers, Diluents & Binders
63 Coating Systems & Additives
50 Thickeners and Stabilizers
47 Solubilizers
46 Direct Compression
45 Taste Masking
42 Parenteral
38 Controlled & Modified Release
36 Topical
35 Disintegrants & Superdisintegrants
30 Film Formers & Plasticizers
29 Granulation
25 Lubricants & Glidants
23 Chewable & Orodispersible Aids
20 Co-Processed Excipients
17 Emulsifying Agents
14 Rheology Modifiers
10 API Stability Enhancers
9 Empty Capsules
7 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 35 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
35 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 33 Finished Drug Prices

1 US Medicaid Prescriptions
33 Finished Drug Prices

MARKET PLACE

129 APIs, 10 FDF Dossiers, 1 Intermediates

129 APIs
10 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

6 US Patents

6 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 2 USP, 3 JP, 1 Others

1 EDQM
2 USP
3 JP
1 Others

$ API Ref.Price (USD/KG) : 1,889 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6ENDO OPERATIONS

filter Patent Number Reset all filters

6 All

01 17229636

02 17404489

03 17879349

04 18003353

05 18940714

06 19415007

filter API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 3Y

02 3Blank

filter Expiration Date Reset all filters

6 All

01 12024-02-26

02 12024-03-12

03 12024-07-28

04 32024-08-01

Product Main Page

01

ENDO OPERATIONS

2024 ACI Convention

Not Confirmed

ENDO OPERATIONS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-08-01

CYANOCOBALAMIN

US Patent Number : 7879349

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21642

Patent Use Code : U-1152

Delist Requested :

Patent Use Description : CYANOCOBALAMIN ADMINIS...

Patent Expiration Date : 2024-08-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

ENDO OPERATIONS

2024 ACI Convention

Not Confirmed

ENDO OPERATIONS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-08-01

CYANOCOBALAMIN

US Patent Number : 8003353

Drug Substance Claim :

Drug Product Claim :

Application Number : 21642

Patent Use Code : U-817

Delist Requested :

Patent Use Description : NASAL ADMINISTRATION O...

Patent Expiration Date : 2024-08-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

ENDO OPERATIONS

2024 ACI Convention

Not Confirmed

ENDO OPERATIONS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-02-26

CYANOCOBALAMIN

US Patent Number : 8940714

Drug Substance Claim :

Drug Product Claim :

Application Number : 21642

Patent Use Code : U-1152

Delist Requested :

Patent Use Description : CYANOCOBALAMIN ADMINIS...

Patent Expiration Date : 2024-02-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

ENDO OPERATIONS

2024 ACI Convention

Not Confirmed

ENDO OPERATIONS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-07-28

CYANOCOBALAMIN

US Patent Number : 9415007

Drug Substance Claim :

Drug Product Claim :

Application Number : 21642

Patent Use Code : U-1896

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-07-28

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

ENDO OPERATIONS

2024 ACI Convention

Not Confirmed

ENDO OPERATIONS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-08-01

CYANOCOBALAMIN

US Patent Number : 7229636

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21642

Patent Use Code : U-817

Delist Requested :

Patent Use Description : NASAL ADMINISTRATION O...

Patent Expiration Date : 2024-08-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

ENDO OPERATIONS

2024 ACI Convention

Not Confirmed

ENDO OPERATIONS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-03-12

CYANOCOBALAMIN

US Patent Number : 7404489

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21642

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-03-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?